Prochlorperazine is classified as a Category C drug in the UK, meaning it should only be used during pregnancy if the potential benefit justifies the possible risk to the fetus. Discuss your individual situation with a healthcare professional before deciding.
Weight changes are not a common side effect of prochlorperazine. However, some patients report increased appetite or mild weight fluctuations, usually related to changes in nausea control rather than a direct drug effect.
Both drugs are dopamine antagonists used for nausea, but prochlorperazine (Compazine) generally has a stronger antipsychotic profile and may cause more extrapyramidal side effects. Metoclopramide also promotes gastric emptying, which prochlorperazine does not.
Severe dizziness may indicate excessive sedation or a drop in blood pressure. Sit or lie down immediately, avoid standing quickly, and contact your prescriber to review the dose or consider an alternative therapy.
Alcohol can enhance the sedative effects of prochlorperazine, increasing the risk of drowsiness and impaired judgment. It is advisable to limit or avoid alcohol until you understand how the medication affects you.
Concurrent use of multiple anti-emetics should be coordinated by a clinician, as combined dopamine blockade can raise the risk of side effects such as extrapyramidal symptoms or excessive sedation.
Typical inactive components include lactose, microcrystalline cellulose, and magnesium stearate. Patients with lactose intolerance should verify the exact formulation with their pharmacist.
Prochlorperazine is not listed as a prohibited substance by the World Anti-Doping Agency (WADA). However, pilots may be subject to specific aviation medical regulations; they should disclose all medications to the licensing authority.
The tablet remains stable as long as it is kept in its original container, tightly sealed, and stored at room temperature. Once past the printed expiry date, the medication should be disposed of safely.
When a brand name becomes expensive, physicians may consider prescribing the generic form (prochlorperazine 5 mg tablets), which is typically less costly. Discuss pricing options with your pharmacist or GP.
Compazine is a brand-name medication that contains prochlorperazine as its active ingredient. It is formulated as a 5 mg oral pill and is classified in the United Kingdom as a medication for digestive health, primarily used to treat nausea and vomiting. Compazine is a prescription-only product (POM) regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).
Prochlorperazine belongs to the phenothiazine class of drugs. Its anti-nausea effect comes from:
These actions help control nausea caused by surgery, chemotherapy, migraine, or other gastrointestinal disturbances.
Compazine is approved by the MHRA for the following indications:
The medication is intended for adult patients; use in children is limited and requires specialist supervision.
Some clinicians prescribe prochlorperazine for conditions that lie outside its official label, such as:
These uses are not approved by the MHRA and should only be undertaken under the direct supervision of a qualified healthcare professional. Off-label prescribing requires an individualized risk-benefit assessment.
If any of these serious reactions occur, seek urgent medical attention.
Patients should disclose all current medications, over-the-counter products, and herbal supplements to their prescriber.
Regular follow-up appointments allow the prescriber to assess effectiveness and adjust the dose as needed.
This article provides educational information about Compazine and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
